Skip to main content

Tagged With "State Honor Roll Report"

Blog Post

2016 Spring Allergy Capitals Report Ranks The Most Challenging Cities Nationwide For Allergies

AAFA Community Services ·
Today, the Asthma and Allergy Foundation of America (AAFA), a leading patient advocacy organization in the United States representing nearly 61 million Americans who experience asthma or allergies, released its annual Spring Allergy Capitals™ report. The report identifies the 100 most challenging places to live with spring allergies in the U.S. Jackson, MS is the most challenging U.S. city to live for the second year in a row based on higher than average pollen scores, higher than average...
Blog Post Featured

2018 Asthma Capitals Report Identifies Nation’s “Asthma Belts”

AAFA Community Services ·
About 25 million Americans have asthma. There is no cure. But you can manage it with a proper treatment plan and by avoiding triggers. But there might be one thing out of your control that can make managing asthma a challenge: where you live. Today, the Asthma and Allergy Foundation of America (AAFA) has released the 2018 Asthma Capitals™ report. This report ranks the top 100 cities in the U.S. where it’s challenging to live with asthma.
Blog Post Featured

2018 Fall Allergy Capitals Report: Is Your City on Our List?

AAFA Community Services ·
Ragweed and other fall allergens are found throughout the U.S., but some areas feel the effects more than others. The Asthma and Allergy Foundation of America (AAFA) has released the 2018 Fall Allergy Capitals™ report.
Blog Post Featured

2018 Spring Allergies Capitals Report: How Does Your City Rank?

AAFA Community Services ·
As many in the U.S. put away their winter coats, they pull out the allergy medicines. The onslaught of pollen that comes each spring affects millions of Americans with seasonal allergies. The Asthma and Allergy Foundation of America (AAFA) has released the 2018 Spring Allergy Capitals™ report that ranks the top 100 cities in the nation for spring allergies
Blog Post Featured

2019 Spring Allergy Capitals: See If Your City Made Our List

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA) has released the 2019 Spring Allergy Capitals™ report to look at why some locations are more affected than others. Our report ranks the top 100 cities in the nation for spring allergies.
Blog Post Featured

2020 Allergy Capitals™ Report: Seasonal Rankings by City for Spring and Fall

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA) 2020 Allergy Capitals™ report is now available. This report ranks the top 100 most challenging cities in the continental United States to live in with seasonal allergies. AAFA combines data from both spring and fall to create a ranking of the top 100 cities based on: Pollen counts Allergy medicine use Number of board-certified allergists available The report also includes a breakdown of seasonal rankings of the top cities for both spring...
Blog Post

3 New Studies Shed Light on Penicillin Allergy

AAFA Community Services ·
At some point you may have had a reaction to penicillin and were told you were allergic. And there’s a good chance it has stayed in your chart throughout your childhood and into adulthood. But 9 of 10 Americans who think they have a penicillin allergy have either outgrown it or never had it in the first place. That said, it’s important to get tested by an allergist to know if you have a true penicillin allergy so you know whether to avoid the drug.
Blog Post

5 Ways to Show Your #TealLove to Someone With Asthma or Allergies This Valentine's Day

AAFA Community Services ·
Valentine's Day is the time of year when you show your loved ones how much they mean to you. However, many typical gifts and activities can be asthma or allergy triggers. #TealLove means choosing gifts that are allergy and asthma friendly.
Blog Post

A High Number of Adults Manage Atopic Dermatitis

AAFA Community Services ·
Atopic dermatitis (AD) is a chronic condition where your skin becomes dry and itchy too easily. This can lead to allergies and inflammation. It is more common in children than adults. But current research suggests that more adults may have it than once thought. AD is also sometimes called eczema. There is no cure.
Blog Post

AAFA Blog Named One of Best Asthma Blogs of 2018

AAFA Community Services ·
We are proud to announce that the Asthma and Allergy Foundation of America’s blog has again been named one of the best asthma blogs by Healthline in 2018! Healthline is a health site with information on many health topics.
Blog Post

AAFA Blog Selected as One of the Best Asthma Blogs of 2017

AAFA Community Services ·
We are proud to announce that the Asthma and Allergy Foundation of America’s blog has been named one of the best asthma blogs of 2017 by Healthline ! Healthline is a health site with information on several different topics. We could not have received this honor without all of our supporters and members. Our blog will continue to bring you information about asthma and allergic diseases like: Asthma and allergy news and research Managing allergic diseases Inspiring stories Medicine recalls...
Blog Post

AAFA Co-Sponsored Report Provides Recommendations for Food Allergy Research, Treatment, and Policy

AAFA Community Services ·
[Press Release] PR Contact: Adam Bailine, Vice President, Marketing & Communications (202) 466-7643, ext. 254 abailine@aafa.org AAFA Co-Sponsored Report Provides Recommendations for Food Allergy Research, Treatment, and Policy With support from the Asthma and Allergy Foundation of America (AAFA), the National Academies of Sciences, Engineering, and Medicine releases a monumental report that makes recommendations to increase our understanding of and approaches to food allergies November...
Blog Post

AAFA Elevates Patient Voice in ICER Review of New Peanut Allergy Treatments

AAFA Community Services ·
On June 11, 2019, in Oakland, California, the Institute for Clinical and Economic Review (ICER) and its California Technology Assessment Forum (CTAF) met to assess the clinical effectiveness and value of treatments for peanut allergy. The review examined two new technologies to induce immune tolerance — Viaskin® Peanut (DBV Technologies) and AR101 (Aimmune Therapeutics) — as well as non-commercialized oral immunotherapy (OIT).
Blog Post

AAFA Mourns the Passing of Congressman Elijah Cummings, Asthma and Allergy Advocate

AAFA Community Services ·
On Oct. 17, 2019, Representative Elijah Cummings (D-MD) passed away. Representative Cummings was an influential voice in support of people with asthma and allergies.
Blog Post Featured

AAFA Names 15 States to 2016 State Honor Roll™ of Asthma and Allergy Policies for Schools

AAFA Community Services ·
The 2016 State Honor Roll™ of Asthma and Allergy Policies for Schools (SHR) report identifies states that make it a priority to create healthy school settings for students with asthma and allergies. This annual report lists states with comprehensive laws and policies aimed at keeping children with asthma and allergies healthy at school.
Blog Post

AAFA's Blog Named One of Healthline's Best Asthma Blogs of 2019

AAFA Community Services ·
We are honored that the Asthma and Allergy Foundation of America’s blog has again been named one of the best asthma blogs by Healthline for 2019! Healthline is a health site with information on many health topics.
Blog Post

AAFA Study Highlights Negative Impact Eczema Can Have on Quality of Life

AAFA Community Services ·
If you’ve never suffered from eczema, also known as atopic dermatitis, you probably aren’t aware of the negative impact it can have on quality of life. The severe itching, redness and excessively dry skin all make life miserable for those who suffer from the allergic disease.
Blog Post

AAFA Tackles Childhood Asthma and Allergies

AAFA Community Services ·
Asthma and allergies impact one in five children in the United States. The Asthma and Allergy Foundation of America (AAFA) exhibited at the 2019 American Academy of Pediatrics (AAP) conference to learn the latest news in pediatrics and to talk to health care providers about the programs and services we offer.
Blog Post

AAFA Urges Inclusion of Patient Voice in Analysis of Costly New Asthma Drugs

AAFA Community Services ·
Biologics are a new class of drugs that fight disease at the source . Instead of attacking symptoms, these drugs target diseases like asthma at a molecular level. These newer types of drugs are more expensive than older medicines. That is prompting public discussion on how to pay for them. The cost of caring for patients with the most severe forms of asthma represents a majority of asthma healthcare spending. In addition, asthma is a leading cause of missed time from work and school. Last...
Blog Post

Advances in Asthma and Allergies in 2019

AAFA Community Services ·
These are just a few things we were able to do this year for the asthma and allergy community because of you. But there is more for us to do to significantly reduce the burden of these diseases on people with asthma and allergies. And we can with your help.
Blog Post

Aetna Decides FeNO Testing Is Medically Necessary for Its Members With Asthma

AAFA Community Services ·
Circassia Pharmaceuticals, Inc., a specialty pharmaceutical company focused on respiratory disease, is pleased to announce that Aetna, one of the largest health insurance companies in the United States, has updated its Exhaled Breath Tests Clinical Policy to include the measurement of exhaled nitric oxide as “medically necessary” for the evaluation of asthma and for monitoring the response to long-term control therapy.
Blog Post

Air Pollution Causes Asthma Symptoms for One Hartford Resident

AAFA Community Services ·
Lakia Shavon Lightner has vivid memories from her childhood of visits to the emergency room at 2 in the morning. She has had severe asthma and allergies for as long as she can remember. She grew up in Hartford, but now lives in East Hartford, Connecticut, our #13 Asthma Capital for 2019.
Blog Post

Alert: FDA Requests Removal of All Ranitidine Products (Zantac) From the Market

AAFA Community Services ·
The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac). The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperature
Blog Post

Ask Your Senators to Approve Increased Funding for the National Asthma Control Program

AAFA Community Services ·
Happy 20th Birthday to the National Asthma Control Program (NACP) of the Centers for Disease Control and Prevention (CDC)! We are thrilled to see that our advocacy efforts are paying off. We applaud the House Appropriations Committee for approving the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Bill, 2020 today to increase to program funding to $34 million. We hope the Senate will do the same.
Blog Post

Asthma and Allergy Caucus to FDA: Take Action to Prevent Albuterol Shortages

AAFA Community Services ·
Congressmen Eliot L. Engel (D-NY) and Fred Upton (R-MI), Co-Chairs of the Asthma and Allergy Caucus, joined by Congressmen TJ Cox (D-CA) and Peter King (R-NY), Members of Caucus, led 57 Members of the House on a letter to the Food and Drug Administration (FDA) about shortages of albuterol inhalers, which are critical to effective asthma management.
Blog Post Featured

Asthma and Allergy Foundation of America Responds to Premature ICER Review of New Peanut Allergy Treatments

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA) addresses concerns regarding the Final Evidence Report assessing the clinical effectiveness and value of treatments for peanut allergy released by the Institute for Clinical and Economic Review (ICER) on July 10, 2019. ICER’s report may cause concern for the allergy community that the findings will restrict access to new treatments for peanut allergy.
Blog Post

Asthma Drug Shortages During COVID-19: A Letter From AAFA’s President and CEO

AAFA Community Services ·
Because of the COVID-19 (new coronavirus) pandemic, we are facing a challenging and unprecedented time. COVID-19 is a respiratory infection, and the nearly 25 million Americans with asthma are at high risk for complications from the virus. As the leading patient organization for people with asthma and allergies, this has the Asthma and Allergy Foundation of America (AAFA) deeply concerned for your health and well-being.
Blog Post

Medication Recall Alert: Puriton Eye Relief Drops Due to Non-Sterile Production Conditions

AAFA Community Services ·
Kadesh Incorporation Issues Voluntary Nationwide Recall of Puriton Eye Relief Drops Due to Non-Sterile Production Conditions For Immediate Release November 7, 2018 Contact Consumers Recall Department contact@puriton.us Announcement Kadesh, Inc. of Garden Grove, CA is voluntarily recalling all lots of Puriton Eye Relief Drops, 0.5 oz. (15ml) bottle, UPC 7 36972 1679 0, to the consumer level. During a recent FDA inspection, investigators observed that ophthalmic drugs, which are required to be...
Blog Post

Back-to-School: Students and Asthma Inhalers

AAFA Community Services ·
Did you know your state allows students to self-carry a quick-relief asthma inhaler while at school? Every state has a policy that allows students in public schools to self-carry, although each has its own procedures. This applies to every state in the U.S. Now is the time of year to get your school forms signed by your child's doctor. These forms include your child's asthma action plan and medication authorization form. Asthma is the leading cause of school absences due to a chronic...
Blog Post

Breathing in the Boat: It Was All Worth It

Megan Roberts ·
On Oct. 14, 2017, I began my travel across the world to compete at the 13th International Dragon Boat Federation’s Nations World Championships on Dianchi Lake in Kunming, China, after a long and unlikely journey to overcome asthma symptoms that nearly prevented me from competing at all.
Blog Post

CERTIFIED Baby Mattress Creates a Healthier Environment for Infants With Asthma and Allergies

AAFA Community Services ·
Pure Zees recently announced the expansion of its innovative asthma & allergy friendly® mattresses into the U.S. market, unveiling a new U.S. website to help roll out multiple related products through 2020. The Irish-based company has secured coveted certification for their signature infant mattress from both Allergy Standards Limited of Ireland (ASL) and The Asthma and Allergy Foundation of America (AAFA).
Blog Post

Clean Economy Act Would Benefit Millions of People With Asthma and Allergies by Addressing Climate Crisis

AAFA Community Services ·
U.S. Senator Tom Carper (D-Del.), top Democrat on the U.S. Senate Environment and Public Works Committee, was joined by 32 Senators in introducing legislation that would put the United States on a path to achieve net-zero greenhouse gas emissions by no later than 2050.
Blog Post

Creating an Asthma Management Plan in Philadelphia, Pennsylvania, the #4 Asthma Capital

AAFA Community Services ·
When Joey was 4 years old, his parents took him to see an allergist. He was having trouble breathing and having challenges with his digestive system. They learned that Joey has asthma triggered by environmental and food allergies.
Blog Post

CVS Sinus Relief Nasal Mist Recalled Due to Contamination

AAFA Community Services ·
Holly Hill, FL, Product Quest Manufacturing (“Product Quest”) is voluntarily recalling Lot# 173089J of CVS Health 12 Hour Sinus Relief Nasal Mist, a clear, colorless liquid, to the consumer level. The product was found to have had microbiological contamination identified as Pseudomonas aeruginosa.
Blog Post

Does Your School Stock Medicine for Asthma Emergencies?

AAFA Community Services ·
Does your state allow schools to stock quick-relief medicines for asthma? Quick-relief medicines , such as albuterol, act fast to relax tight muscles around your airways. This allows the airways to open up so air can flow through them. Congress is considering a law to encourage states to permit these “ albuterol stocking ” school policies . The School-Based Asthma Management Programs Act builds upon a similar law that encourages states to require schools to stock epinephrine auto-injectors.
Blog Post Featured

Dr. Philip Norman: An AAFA Tribute to an Allergy Legend

AAFA Community Services ·
If you’ve ever benefited from immunotherapy (allergy shots, SLIT or oral immunotherapy), you can thank Dr. Philip Sidney Norman. Dr. Norman put allergy research on the map. He is known as the “father of modern immunotherapy for allergic disease” and even coined the term “allergen immunotherapy.” As an allergist and researcher for more than 50 years, he published 237 research papers and more than 100 book chapters and reviews. And for many decades, he was an important part of AAFA.
Blog Post

Dupilumab Shows Benefit for Those With Severe Asthma During Clinical Trial

AAFA Community Services ·
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the Phase 3 investigational study evaluating dupilumab in adults and adolescents with severe, steroid-dependent asthma met its primary endpoint and key secondary endpoints.
Blog Post

Elijah E. Cummings Family Asthma Act Would Expand Efforts to Improve Care for People With Asthma

AAFA Community Services ·
Representatives Eliot L. Engel (D-NY-16), Fred Upton (R-MI-06), Pete King (R-NY-02) and TJ Cox (D-CA-21), all members of the House Asthma and Allergy Caucus, have introduced legislation to honor Elijah E. Cummings’ long-time advocacy for those living with asthma. The Elijah E. Cummings Family Asthma Act would expand federal, state, and local efforts to improve care for individuals with asthma.
Blog Post

Family Keeps Memory of 13-Year-Old Sports Star Alive Through Asthma Awareness Efforts

AAFA Community Services ·
Tiffany Phu loved sports and spent most of her time outdoors. So it was fitting that on a balmy May night, her older sister Michelle confidently threw out the first pitch at a Philadelphia Phillies game. Michelle advocates for asthma awareness in memory of her sister Tiffany. “Tiffany enjoyed playing all types of sports,” notes Michelle. Tiffany died from asthma two years earlier, in May 2014, after running track at her Texas school. The eighth grader was just 13. The sudden and tragic loss...
Blog Post

FDA Approves Dupixent® for Treatment of Asthma

AAFA Community Services ·
The FDA has approved another biologic treatment, Dupixent, for the treatment of both moderate and severe asthma patients with eosinophilic phenotype and oral corticosteroid-dependent asthma, regardless of phenotype.
Blog Post

FDA Approves Removal of Asthma-Related Death Box Warnings From Certain Asthma Medicines

AAFA Community Services ·
FDA's most prominent warning, the Boxed Warning, about asthma-related death has been removed from the drug labels of medicines that contain both an ICS and LABA. A FDA review of four large clinical safety trials shows that treating asthma with long-acting beta agonists (LABAs) in combination with inhaled corticosteroids (ICS) does not result in significantly more serious asthma-related side effects than treatment with ICS alone.
Blog Post

FDA Approves Spiriva Respimat to Treat Asthma In Children Ages 6-12

AAFA Community Services ·
[Press Release] FDA Expands Approval of SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray for Maintenance Treatment of Asthma in Children Steroid-free SPIRIVA RESPIMAT now approved as asthma treatment for age 6 and older Supplemental New Drug Application (sNDA) approved under priority review from the FDA FDA also granted pediatric exclusivity to SPIRIVA RIDGEFIELD, Conn., Feb. 16, 2017 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and...
Blog Post

FDA Approves Two New Asthma Inhalers

AAFA Community Services ·
[Press Release] Teva Announces FDA Approval of Two New RespiClick® Maintenance Inhalers for the Treatment of Asthma Approvals Expand Portfolio of Respiratory Medicines Delivered in RespiClick® Inhaler Designed to Eliminate the Need for Hand-Breath Coordination During Inhalation JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) announced that the U.S. Food and Drug Administration (FDA) approved two products for adolescent and adult patients with asthma.
Blog Post

FDA Warns of Fraudulent and Unapproved Flu Products

AAFA Community Services ·
As part of the U.S. Food and Drug Administration’s ongoing efforts to protect consumers from health fraud, the agency is reminding consumers to be wary of unapproved products claiming to prevent, treat or cure influenza, or flu. This year’s severe flu season raises new concerns about the potential for consumers to be lured into buying unproven flu treatments, and even worse, buying counterfeit antivirals online from websites that appear to be legitimate online pharmacies.
Blog Post

February Advocacy Update: Over-the-Counter Medicines, Restaurant Safety and Cleaner Cars

Jenna R. ·
Welcome to your February advocacy update. I’m Jenna Riemenschneider, director of advocacy at the Asthma and Allergy Foundation of America (AAFA). I am pictured above with AAFA board member Renuka Babu Brown and Senator Ed Markey's (D-MA) policy advisor Adam Axler. Over-the-Counter Drug Access and Cleaner Cars Rollbacks AAFA and other members of the Healthy Choices Coalition met with Representative Judy Chu's office. We asked her to co-sponsor the Restoring Access to Medication Act of 2019...
Blog Post

Fighting for Air in Detroit, Michigan, the #16 Asthma Capital

AAFA Community Services ·
Shari Duncan has had asthma for more than three decades. In recent years it has become quite severe. Shari takes daily asthma maintenance medicines, does nebulizer breathing treatments and works hard to avoid her biggest asthma triggers. She also uses her quick-relief inhaler about once or twice a week. In spite of these efforts, four to six times a year Shari is hospitalized for asthma.
Blog Post Featured

Food Allergies and the Emotional, Social and Financial Impact

AAFA Community Services ·
AAFA released the My Life With Food Allergy: Parent Survey Report. This report summarizes the emotional, social and financial impact on the parent or caregiver of a child with food allergies.
Blog Post

GlaxoSmithKline Study Shows Nucala Improves Quality of Life, Lung Function in Severe Asthma

AAFA Community Services ·
GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data demonstrating that severe asthma patients, whose disease is driven by eosinophilic inflammation, treated with first-in-class biologic Nucala® (mepolizumab) added-on to standard of care, achieved clinically and statistically significant improvements in their health-related quality of life and lung function, when compared to patients treated with placebo and standard of care. These results are from the phase IIIb MUSCA study (NCT02281318, 200
Blog Post

Global Climate Change Is a Rapidly Growing Health Emergency

AAFA Community Services ·
New research shows that climate change is already a significant public health issue and a looming global health emergency. Its findings, outlined in The Lancet medical journal, demonstrate the various ways climate change is already affecting the health of people across the planet, today.
Blog Post

Global Initiative for Asthma (GINA) Recommends the Use of Fractional Exhaled Nitric Oxide (FeNO) Monitoring for Difficult-to-Treat and Severe Asthma Management

AAFA Community Services ·
Circassia Pharmaceuticals, Inc. (“Circassia” or “the Company”), a specialty pharmaceutical company focused on respiratory disease, today announced that Fractional Exhaled Nitric Oxide (FeNO) monitoring is recommended in the latest Global Initiative for Asthma (GINA) guide, “Difficult-to-Treat & Severe Asthma in Adolescent and Adult Patients – Diagnosis and Management.”
 
×
×
×
×